Tiziana Life Sciences Announces Agreement with STC Biologics for GMP Manufacturing of an anti-Interleukin-6-Receptor Monoclonal Antibody for Clinical Studies in Patients with COVID-19

Stock Information for Tiziana Life Sciences plc

Loading

Please wait while we load your information from QuoteMedia.